Shantha Biotechnics Limited is an Indian biotechnology company headquartered in Hyderabad, India. It is the first Indian company to develop, manufacture, and market recombinant human healthcare products in India. The company is a wholly owned subsidiary of the Sanofi group.[1]
Shantha Biotechnics caters to major international markets including Asia-Pacific, Africa, Commonwealth of Independent States, and Latin America in addition to international organisations UNICEF and PAHO.
History
Shantha Biotechnics, Ltd. began with the initiatives of Dr. K. I. Varaprasad Reddy and Khalil Ahmed. Varaprasad and Ahmed established the company in 1993 to produce affordable drugs for the general population, while maintaining international standards in quality.[1] The project originated as an R&D project at Osmania University under the industry-university interactive programme in 1993, and later operated from the Center for Cellular and Molecular Biology until an independent research and development facility was built.